Federica Cattaneo - Concepedia

Author

Federica Cattaneo

Also Known As

Cattaneo, Federica, F CATTANEO, F Cattaneo, F. Cattaneo, Federica Cattaneo, Federica MARINCOLA CATTANEO, Federica Marincola Cattaneo, Francoise Cattaneo

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Chiesi (Italy)Rigshospitalet The San Raffaele Telethon Institute for Gene Therapy Copenhagen University Hospital Vita-Salute San Raffaele University

About

Federica Cattaneo is an author at Chiesi (Italy) specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.4K
2	Cell Biology	3	3	1.3K
3	Health Sciences	2	2	1.2K
4	Cellular Therapies	2	2	1.2K
5	Public Health	1	1	16

Federica Cattaneo

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning Alessandro Aiuti, Shimon Slavin, Memet Aker, Science Cell TherapyImmunologyNonmyeloablative ConditioningCell Replacement TherapyImmunotherapy	2002	1.1K
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency Alessandro Aiuti, Federica Cattaneo, Stefania Galimberti, New England Journal of Medicine	2009	997
Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B Wolfgang Miesbach, Karina Meijer, Michiel Coppens, Blood	2017	295
WASP regulates suppressor activity of human and murine CD4+CD25+FOXP3+ natural regulatory T cells Francesco Marangoni, Sara Trifari, Samantha Scaramuzza, The Journal of Experimental Medicine	2007	181
IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivo Mike Recher, Lucinda J. Berglund, Danielle T. Avery, Blood	2011	151
Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients Sabine Charrier, Loı̈c Dupré, Samantha Scaramuzza, Gene Therapy Cell TherapyWas PatientsWasp ExpressionImmunologyLentiviral Vectors	2006	114
Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients Barbara Cassani, Massimiliano Mirolo, Federica Cattaneo, Blood	2008	75
Efficacy of a Fosfomycin-Containing Regimen for Treatment of Severe Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii: A Prospective, Observational Study Alessandro Russo, Matteo Bassetti, Valeria Bellelli, Infectious Diseases and Therapy Antimicrobial SusceptibilityHealth SciencesAntibioticsMultidrug-resistant Acinetobacter BaumanniiObservational Study	2020	68
Efficacy and safety of Velmanase alfa in the treatment of patients with alpha‐mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double‐blind, randomised, placebo‐controlled trial Line Borgwardt, Nathalie Guffon, Yasmina Amraoui, Journal of Inherited Metabolic Disease	2018	59
Comprehensive long‐term efficacy and safety of recombinant human alpha‐mannosidase (velmanase alfa) treatment in patients with alpha‐mannosidosis Allan M. Lund, Line Borgwardt, Federica Cattaneo, Journal of Inherited Metabolic Disease	2018	55

Page 1